SecBot SecBot

ALTO

Alto Ingredients, Inc.
Nasdaq· Industrial Organic Chemicals· Inc. DE· CIK 0000778164 Biotech & Drug Discovery
$3.68 +0.08 (+2.08%)
Oct 26 4:00 PM ET · prev $3.61
Market cap
$278.5M
Micro cap
Consensus
Buy
89% Buy or better · 9 analysts
Median target
$8.00
+117% · range $7.00–10.00
Next earnings
Nov 9
in 14 days
1 year
+247.6%
from $1.06 · Oct 27
30 days
+0.4%
from $3.67
52-week range
$1.01–5.99
−38% from high · low Oct 31
Avg volume 20D
947.5K
shares / day
Short interest
5.94M
≈7.7% of shares · −8.8%
Days to cover
5.0
at average volume
Insider net
+$361.2K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 1 exit
SecBot read BEARISH 1 report · 90 days
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·Next Earnings date, Nov 9, 2026
Strongest BEARISH A mixed institutional cluster in ALTO shows 22 buyers accumulating $20.0M in new positions (dominated by…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $361.2K at an average $4.25. No open-market sales. Price is 13% below their cost.

  • InstitutionsBULLISH

    Q2 2026: 22 added (0 new), 13 trimmed or exited.

  • AnalystsBULLISH

    8 of 9 rate it Buy or better. Every target is above the price.

  • Short sellersSTEADY

    Short interest −8.8% to 5.94M shares. 5.0 days to cover, ≈7.7% of shares.

  • TrendDOWNTREND

    5% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
1
exit
FundMoveSharesValue
BlackRock, Inc.DOUBLED5,495,025$31.3M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPADD2,280,128$13.0M
GEODE CAPITAL MANAGEMENT, LLCDOUBLED1,980,080$11.3M
STATE STREET CORPDOUBLED1,230,173$7.0M
DIMENSIONAL FUND ADVISORS LPADD1,143,740$6.5M
Connor, Clark & Lunn Investment Management Ltd.DOUBLED855,702$4.9M
JACOBS LEVY EQUITY MANAGEMENT, INCDOUBLED827,481$4.7M
NORTHERN TRUST CORPDOUBLED784,047$4.5M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

9 analysts
Buy 89% rate it Buy or better
Strong Buy2Buy6Hold1Sell0Strong Sell0
12-month targets · 3 analysts

Price is below the lowest target. Median implies +117%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Sep 30, 2026StoneX
INITIATE
INITIATEBuy
May 7, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$361.2K
bought · 1 insider
$0
sold · 0 insiders
−13.3%
vs their $4.25 cost
DateInsiderTypeValue
Sep 14, 2026
NATHAN GILBERT E
Director
BUY$39.3K
Aug 11, 2026
NATHAN GILBERT E
Director
BUY$207.5K
Jun 23, 2026
Gray Maria G
Director
AWARD23,605 sh
Jun 23, 2026
Nury Dianne S.
Director
AWARD23,605 sh
Jun 23, 2026
Tank Alan Robert
Director
AWARD23,605 sh
Jun 23, 2026
NATHAN GILBERT E
Director
AWARD31,652 sh
May 14, 2026
Graham Auste M
CLO & Secretary
GIFT20,000 sh
May 13, 2026
NATHAN GILBERT E
Director
BUY$22.3K

Earnings setup

Estimates
Nov 9
reports in 14 days

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Sep 30, 2026
5,943,360
shares short
-8.8%
vs prior settlement
5.0
days to cover
≈7.7%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 22, 2026 SEC
A mixed institutional cluster in ALTO shows 22 buyers accumulating $20.0M in new positions (dominated by passive/index…
INST-CLUSTER — Impact 4/10
Sep 14, 2026 Insider
NATHAN GILBERT E bought 10,000 shares
Director @ $3.93 ($39.3K)
Aug 11, 2026 Insider
NATHAN GILBERT E bought 50,000 shares
Director @ $4.15 ($207.5K)
Aug 5, 2026 Earnings calendar
ALTO Q2 2026 Earnings Scheduled — 2026-08-05
Jun 30, 2026 Inst.
BlackRock, Inc. — DOUBLED
5,495,025 shares ($31.3M)
Jun 30, 2026 Inst.
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP — ADD
2,280,128 shares ($13.0M)
Jun 23, 2026 SEC
Alto Ingredients filed an 8-K confirming stockholder approval of the 2026 Omnibus Incentive Plan and the election of…
8-K — Impact 3/10
Jun 23, 2026 Insider
Gray Maria G was granted 23,605 shares
Director
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 9, 2026
Earnings date
ALTO Q3 2026 Earnings Scheduled — 2026-11-09
Recent
Aug 5, 2026
Earnings date
ALTO Q2 2026 Earnings Scheduled — 2026-08-05
Jul 15, 2026
Short interest
Short Interest: ALTO up 39% to 5.7M shares
Settlement 2026-07-15 | Days to cover: 2.53 | ≈7.40% of shares outstanding (est.)
Jun 30, 2026
Short interest
Short Interest: ALTO up 81% to 4.1M shares
Settlement 2026-06-30 | Days to cover: 1.29 | ≈5.32% of shares outstanding (est.)
Jun 29, 2026
Press release
Alto Ingredients, Inc. Added to Russell 2000® and Russell 3000® Indexes
PEKIN, Ill., June 29, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of renewable fuels…
Jun 15, 2026
Press release
Alto Ingredients, Inc. Completes Transaction to Monetize All 2025 45Z Clean Fuel Production Tax Credits
PEKIN, Ill., June 15, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols…

SecBot reports

7 filings · 1 press release · 1 bullish · 1 bearish · 1 mixed · 4 neutral
All ALTO filing & press-release reports (8)